GW Pharma (GWPH) says drug not part of halted trial in France - Bloomberg

January 15, 2016 6:40 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

GW Pharma (NASDAQ: GWPH) says drug not part of halted trial in France, according to Bloomberg, citing a phone conversation with the company today.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Litigation, Momentum Movers, Trader Talk